Bladex, Inc. (Banco Latinoamericano de Comercio Exterior, S.A.) — FY2020 Form 20-F
Reporting period and context: This is an audited annual report for the fiscal year ended December 31, 2020, not a standalone fourth-quarter filing. Bladex is a Panama-based multinational bank focused on Latin American trade finance, serving financial institutions, corporations and other institutional clients; it does not take retail deposits. The audited consolidated statements are prepared under IFRS as issued by the IASB. KPMG issued an unqualified opinion on the financial statements and internal controls.
Financial performance and position
Amounts are U.S. dollars; financial results are for the full year, while balance-sheet figures are as of December 31.
| Metric | 2020 | 2019 |
|---|---|---|
| Total revenue | $99.2 million | $126.7 million |
| Net interest income | $92.5 million | $109.5 million |
| Net interest margin / spread | 1.41% / 1.13% | 1.74% / 1.19% |
| Net fees and commissions | $10.4 million | $15.6 million |
| Profit / diluted EPS | $63.6 million / $1.60 | $86.1 million / $2.17 |
| Return on average equity / assets | 6.19% / 0.96% | 8.56% / 1.36% |
| Operating expenses / efficiency ratio | $37.3 million / 37.6% | $40.7 million / 32.1% |
| Assets / equity | $6.29 billion / $1.04 billion | $7.25 billion / $1.02 billion |
| Net loans | $4.90 billion | $5.82 billion |
| Deposits / borrowings and debt, net | $3.14 billion / $1.99 billion | $2.89 billion / $3.14 billion |
| Liquid assets | $1.05 billion | $1.16 billion |
- Cash flow: Net cash from operating activities was $1.247 billion, compared with $92 million used in 2019. The 2020 inflow primarily reflected a $911 million reduction in loans and a $251 million increase in deposits. Investing activities used $320 million, mainly for securities purchases; financing activities used $1.241 billion, chiefly from lower short-term borrowings and debt. Cash and cash equivalents ended the year at $846 million.
- Liquidity and capital: Liquid assets equaled 16.7% of assets and 33.4% of deposits. The reported regulatory capital adequacy ratio was 20.21%, Tier 1 capital to risk-weighted assets (Basel III IRB) was 26.0%, and regulatory leverage ratio was 14.08%. Total equity to assets was 16.5%.
- Credit quality: Credit-impaired loans were $11 million, or 0.22% of the loan portfolio, versus $62 million, or 1.05%, in 2019. Total credit loss allowances were $44.6 million, or 0.75% of the Credit Portfolio, down from $102.5 million, or 1.56%. The Bank recorded a $1.5 million reversal of credit-loss provisions in 2020.
- Portfolio and concentration: The Commercial Portfolio fell 15% to $5.55 billion and the broader Credit Portfolio fell 10% to $5.95 billion. Brazil represented 18% of Commercial Portfolio exposure; the five largest country exposures together represented 56% of Credit Portfolio. Oil and gas loans were 12% of the loan portfolio and agribusiness loans 7%.
Material changes versus 2019
- Profit fell 26% and revenue fell 22%. Management attributed weaker net interest income primarily to lower average loan balances, a defensive preference for liquidity, and lower LIBOR-based rates. The average interest rate earned on loans declined to 3.48% from 4.59%; the average rate paid on interest-bearing liabilities fell to 1.59% from 3.10%.
- Fees and commissions declined 33%, largely reflecting two mandated structured transactions totaling $200 million, versus six transactions totaling $1.3 billion in 2019. Losses on financial instruments widened to $4.8 million from $1.4 million, including fair-value and hedge-related effects.
- Operating expenses decreased 8%, but the efficiency ratio worsened to 37.6% from 32.1% as revenue contracted faster than costs.
- Management reduced lending and tightened underwriting while collecting scheduled maturities. Meanwhile, deposits rose 9%, and net borrowings and debt fell 37%; deposit funding became a larger share of interest-bearing liabilities.
- Credit-impaired loans declined, but 2020 included $56.5 million of loan write-offs against existing allowances. A sale of a Stage 3 impaired exposure generated a $52.1 million write-off; a separate Stage 2 loan sale generated a further write-off. The lower closing allowance therefore reflects write-offs and portfolio changes, not solely improved underlying credit performance.
- The Board reduced the declared annual cash dividend to $1.00 per share from $1.54 as a precautionary measure. Total equity nevertheless increased 2% to $1.04 billion.
Outlook, commentary and risks
- Management planned to resume portfolio growth as conditions improved, restore pre-pandemic balances over time, prioritize established high-quality clients and defensive sectors, and continue prudent liquidity management. It also cited operating efficiency, expansion in stable markets, broader client and country diversification, and development of products such as supply-chain finance and vendor finance. These are plans, not quantified earnings or growth guidance.
- Management described liquidity, asset quality and capitalization as resilient during the pandemic. It activated its Contingent Liquidity Plan, tightened credit approvals, and reported uninterrupted remote operations. The Bank’s results remain exposed to the uncertain duration and economic effects of COVID-19, including borrower stress, delayed recoveries, further provisions, and weaker regional trade and growth.
- Key risks include Latin American country and borrower concentrations; sovereign, political, currency and commodity shocks; reliance on central-bank and institutional deposits; funding-market disruption and rating downgrades; interest-rate and hedge ineffectiveness; cybersecurity and operational risk; sanctions and compliance obligations; and the transition from LIBOR to alternative rates. Panama has no central bank or lender of last resort.
- Ratings at the report date were Fitch BBB/F3 with a negative outlook, Moody’s Baa2/P-2 stable, and S&P BBB/A-2 stable. Fitch had downgraded the Bank in June 2020; Moody’s and S&P had revised their outlooks to stable.
- LIBOR transition work had begun on corporate loans and commitments, with fallback language intended to replace LIBOR with SOFR and a target to complete contract amendments by the end of 2021. Derivative contracts had not yet been amended as of year-end; the filing describes remaining operational and hedge-effectiveness risks.
- One modified special-mention loan had a balance of about $8.8 million and an IFRS allowance of about $1.8 million. The filing also reports $10.9 million of corporate loans using Panama’s moratorium relief, with interest payments up to 30 days in arrears.
- No significant litigation was reported. Management and KPMG concluded disclosure controls and internal control over financial reporting were effective at year-end.
Important facts for investors to verify
- Reconcile the stated $1.247 billion operating cash inflow to the substantial loan runoff and deposit movements; it is not a measure of recurring earnings.
- Review the $56.5 million write-offs, the sale and recovery assumptions for the impaired exposures, and the relationship between reduced impaired loans and the lower allowance balance.
- Track post-year-end loan performance, Stage 2 exposures, modified or moratorium-relief loans, and the adequacy of IFRS expected-credit-loss assumptions under adverse scenarios.
- Verify deposit concentration and stability, especially central-bank and shareholder-related funding, alongside short-term contractual maturities and access to wholesale markets.
- Monitor whether the planned portfolio recovery supports net interest income and fee generation without weakening underwriting or liquidity; also assess the sustainability of margins as interest rates and loan volumes change.
- Confirm dividend declarations and payments: the report states $1.00 per share declared for 2020 but $1.135 per share paid during the year, reflecting payment dates that include an earlier quarterly declaration.
- Resolve a presentation inconsistency: the cover page marks U.S. GAAP, while the filing’s selected financial data, accounting policies and audited statements say IFRS. The financial statements identify IFRS as the accounting basis.